藥要看
選單
藥物證書
藥物成份
藥證廠商
3.Negative control serum, containing 0.099% sodium azide.
許可證數量: 1
4.Affinity purified sheep anti-human IgG (γ chain) fluorescein isothiocyanate conjugate (FITC) containing 0.099% sodium azide.
許可證數量: 1
5.1% Evans Blue, as an optional counterstain.
許可證數量: 1
6.Phospahte buffered saline (PBS), a 20-fold concentrate in liquid form.
許可證數量: 1
7.Blotters to blot around the wells after washing.
許可證數量: 1
8.Mounting medium, containing an anti-fading agent (DABCO, 1, 4, diazabicyclo [2.2.2] octane).
許可證數量: 1
9. Coverslips.
許可證數量: 1
Novaclone Anti-B contains a blend of monoclonal IgM antibodies derived from the murine hybridoma cell lines: F84 3D6, F97 2D6.
許可證數量: 1
pH:0.2%W/W 甲基紅, 2.8%W/W 澳百里香酚藍,97%W/W 非反應物
許可證數量: 1
PQQ Glucose Dehydrogenase ≥ 1.0 Units, Other ingredients (buffer, mediator, etc) ≥ 0.01mg
許可證數量: 1
Reagent 1: DEA 1.5 mol/L; Sodium azide 0.09%
許可證數量: 1
Reagent 2: Paranitrophenyl-Phosphate 60 mmol/L; Sodium azide 0.09%
許可證數量: 1
潛血:6.6%W/W 枯稀過氧化羥基導丙苯,4.0%W/W 3,3’,5,5’-四甲基聯苯胺,89.4%W/W緩衝劑
許可證數量: 1
葡萄糖:16.3%W/W 葡萄糖氧化酶,0.6% W/W 過氧化物酶,7.0%W/W碘化鉀,76.1%W/W緩衝劑和非反應物
許可證數量: 1
葡萄糖:16.3%W/W葡萄糖氧化酶,0.6% W/W 過氧化物酶,7.0%W/W碘化鉀,76.1%W/W緩衝劑 膽紅素:0.4%W/W2.4-二氯苯胺重氮鹽,99.6%W/W緩衝劑 酮類:7.7%W/W亞硝基鐵氰化物,92.3%W/W緩衝劑 比重:2.8%W/W 澳百里香酚藍,69.0%W/W甲基乙烯基醚,馬來酸共聚物,28.2%W/W氫氧化鈉 潛血:6.6%W/W枯稀過氧化羥基導丙苯,4.0%W/W 3,3’,5,
許可證數量: 1
蛋白質:0.3%W/W 四溴酚藍,99.7%W/W緩衝劑和非反應物
許可證數量: 1
Folic Acid contains not less than 97.0% and not more than 102.0% of C19H14N7O6, calculated on the anhydrous basis.
許可證數量: 1
Cal1 Anti-CCP calibrator 1 (white cap), 2 bottles (lyophilized) for 1.0 mL each: Anti-CCP antibodies (human) approx. 20 U/mL in a human serum matrix.
許可證數量: 1
Cal2 Anti-CCP calibrator 2 (black cap), 2 bottles (lyophilized) for 1.0 mL each: Anti-CCP antibodies (human) approx. 200 U/mL in a human serum matrix.
許可證數量: 1
Calibrators: The exact lot-specific calibrator values are encoded in the barcoded labels of the test-specific reagent.
許可證數量: 1
INDOCYANINE GREEN
許可證數量: 4
M Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5 mL: Streptavidin-coated microparticles 0.72 mg/mL; preservative
許可證數量: 1
PC Anti-CCP1: 2 bottles, each for 2.0 mL of control serum Anti-CCP antibodies (human), approx. 30 U/mL in human serum.
許可證數量: 1
PC Anti-CCP2: 2 bottles, each for 2.0 mL of control serum Anti-CCP antibodies (human), approx. 100 U/mL in human serum.
許可證數量: 1
R1 CCP~biotin (gray cap), 1 bottle, 9 mL:Biotinylated cyclic citrullinated peptides (synthetic) approx. 1.1 μg/mL, phosphate buffer 100 mmol/L, pH 5.0; preservative.
許可證數量: 1
R2 Anti-human aggregated IgG~Ru(bpy)2+3 (black cap), 1 bottle, 10 mL:Ruthenylated monoclonal anti-human IgG antibody (mouse) 0.75 μg/mL; phosphate buffer 100 mmol/L, pH 6.0; preservative.
許可證數量: 1
元胡索
許可證數量: 3
Dexamthasone Sodium Phosphate contains not less than 97.0 percent and not more than 102.0 percent of C22H28FNa2O8P, calculated on the water-free and alcohol-free basis.
許可證數量: 1
1.Coated Tubes: 100 tubes coated with anti-Cortisol antibodies (rabbit).
許可證數量: 1
1.Magnetic Particles 2.3mL: Megnetic particles coated with antibody against PTH(39-84), BSA, phosphate buffer, <0.1% sodium azide.
許可證數量: 1
14 ml Tracer solution:anti-TSH tracer, labelled with isoluminol, monoclonal (mouse)
許可證數量: 1
2.0 ml Calibrator, High
許可證數量: 1
2.0 ml Calibrator, low
許可證數量: 1
2.3 ml Magnetic particles suspension:magnetic particles, coated with anti-TSH, monoclonal (mouse)
許可證數量: 1
2.Calibrators: 7 vials of Cortisol in humand serum at the following concentrations: 0, 10, 50, 100, 200, 500 and 800 μg/L. Preservative: NaN3 (<0.1%), Lyophilized.
許可證數量: 1
2.Conjugate 12.0mL: Antibody to PTH(1-34) conjugated to an isoluminol derivative, in phosphate buffer with goat IgG surfactant, and preservatives.
許可證數量: 1
3.Calibratorl (Lyophilized) Horse serum, phosphate buffer, surfactants, 0.2% ProClin 300 and PTH.
許可證數量: 1
3.Radioactive Conjugate: 2 vials (50mL) of 125I-Cortisol in citrate buffer with blocking agent for steroid-binding proteins. Preservative: NaN3 (<0.1%). Radioactivity content: 70 KBq/vial.
許可證數量: 1
4.Calibrator 2 (Lyophilized) House serum, phosphate buffer, surfactants, 0.2% ProClin 300 and PTH.
許可證數量: 1
Control: 5. Control 2mL: pooled plasma (lyophilized 2mL/vial) with ProClin 300 as a preservative.
許可證數量: 1
Metamizole Sodium , when calculated on the dried substance, contains not less than 99% and not more than 101% of C13H16N3NaO4S.
許可證數量: 1
Potassium Chloride, 1.0 mol/L, Preservative
許可證數量: 1
IRON OXIDE-HETITANIUM DIOXIDE SINTER (include 90.1%TiO2)
許可證數量: 1
OCTYLTRIMETHOXYSILANE COATED TITANIUM DIOXIDE
許可證數量: 14
Teicoplanin contains not less than 900 μg (potency) per mg, calculated on the anhydrous, de-sodium chloride and de-residual solvents basis. the potency of Teicoplanin is expressed as mass (potency) of C72-89H68-99Cl2N8-9O28-
許可證數量: 1
TOTAL TITANIUM DIOXIDE
許可證數量: 10
1. Buffer: Good’s buffer, pH 7.4, 2. Antibody: Anti-human IgG antibody (goat)
許可證數量: 1
Each contains:2.3ml Magnetic particles suspension:magnetic particles, coated with anti-T4, polyclonal;1.0 ml Calibrator, low;1.0 ml Calibrator, high;23 ml Tracer solution:T4, labelled with isoluminol
許可證數量: 1
Elecsys Vitamin B12 CalSet II: Reagents - working solutions • B12 Cal1: 2 bottles, each for 1.0 mL of calibrator 1 • B12 Cal2: 2 bottles, each for 1.0 mL of calibrator 2
許可證數量: 1
Elecsys Vitamin B12: Reagents - working solutions PT1 Pretreatment reagent 1 (white cap), 1 bottle, 4 mL: Dithiothreitol 1.028 g/L; stabilizer, pH 5.5.
許可證數量: 1
««
«
162
163
164
165
166
»
»»